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Diastolic Dysfunction Is an Independent Risk
Factor for Death in Patients With Sickle Cell Disease
Vandana Sachdev, MD,* Roberto F. Machado, MD,† Yukitaka Shizukuda, MD, PHD,*
Yesoda N. Rao, MD,* Stanislav Sidenko,* Inez Ernst, RN, RDCS,* Marilyn St. Peter, RDCS,*
Wynona A. Coles, RRT,† Douglas R. Rosing, MD,* William C. Blackwelder, PHD,‡
Oswaldo Castro, MD,§ Gregory J. Kato, MD,† Mark T. Gladwin, MD†‡
Bethesda, Maryland; and Washington, DC
Objectives The goal of this study was to characterize left ventricular diastolic function in the sickle cell disease (SCD) popu-
lation and to relate echocardiographic measures of dysfunction with pulmonary hypertension and mortality.
Background Pulmonary hypertension has been identified as a predictor of death in the adult SCD population. Although dia-
stolic dysfunction is also observed in this population, its prevalence, association with high pulmonary artery sys-
tolic pressure, and attributable mortality remain unknown.
Methods Diastolic function assessment using tissue Doppler imaging was performed in a group of 141 SCD patients. Con-
ventional echocardiographic parameters of diastolic function were performed in a total of 235 SCD patients.
Results Diastolic dysfunction was present in 18% of patients. A combination of diastolic dysfunction and pulmonary hy-
pertension was present in 11% of patients, and diastolic dysfunction accounted for only 10% to 20% of the vari-
ability in tricuspid regurgitation (TR) jet velocity. Diastolic dysfunction, as reflected by a low E/A ratio, was asso-
ciated with mortality with a risk ratio of 3.5 (95% confidence interval 1.5 to 8.4, p  0.001), even after
adjustment for tricuspid regurgitation (TR) jet velocity. The presence of both diastolic dysfunction and pulmonary
hypertension conferred a risk ratio for death of 12.0 (95% confidence interval 3.8 to 38.1, p  0.001).
Conclusions Diastolic dysfunction and pulmonary hypertension each contribute independently to prospective mortality in pa-
tients with SCD. Patients with both risk factors have an extremely poor prognosis. These data support the imple-
mentation of echocardiographic screening of adult patients with SCD to identify high-risk individuals for further
evaluation. (J Am Coll Cardiol 2007;49:472–9) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.09.038(
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hhe hemoglobinopathy of sickle cell disease (SCD) leads to
ntrapment of sickle erythrocytes within the microvascula-
ure, producing episodic vaso-occlusion and ischemia-
eperfusion injury and infarction in multiple organ systems.
lthough the survival of patients in the U.S. and the
eveloped world has increased significantly over the last 3
ecades, the poorly controlled lifelong hemolytic anemia
nd repetitive cycles of organ infarction ultimately lead to a
rogressive systemic vasculopathy and chronic organ failure
rom the *Cardiovascular Branch and the †Vascular Medicine Branch, Echocardi-
graphy Laboratory, National Heart, Lung, and Blood Institute, Bethesda, Maryland;
Critical Care Medicine Department, Clinical Center, National Institutes of Health,
ethesda, Maryland; and the §Center for Sickle Cell Disease, Howard University
ollege of Medicine, Washington, DC. Dr. Gladwin is supported by intramural
unds from the Department of Intramural Research of the National Heart, Lung, and
lood Institute, Bethesda, Maryland, and a Collaborative Research and Development
greement with INO Therapeutics, Clinton, New Jersey. Dr. Gladwin is named as
co-inventor on a patent application by the National Heart, Lung, and Blood
nstitute for the therapeutic use of nitrite.c
Manuscript received May 8, 2006; revised manuscript received September 12, 2006,
ccepted September 28, 2006.1). Related to this vasculopathy is the development of
ulmonary hypertension (PH), mirrored by increasing re-
orts of sudden death (2–4). Pulmonary hypertension has
een closely associated with mortality (2,3,5–8) and was the
ost common finding in a recent autopsy series (9).
We recently reported a prevalence of PH of 32% in a
rospective cohort of 195 SCD patients (5). This diagnosis
as associated with a risk ratio (RR) for death of 10.1 (95%
onfidence interval [CI] 2.2 to 47.0). Although the associ-
tion between increased pulmonary pressures and mortality
s impressive and has been reproduced in multiple studies
8,10,11), the degree of PH is modest (5,12,13), making it
nclear whether this is a cause or a correlate of the increased
ortality. A central controversy in the field involves the
ontribution of left ventricular (LV) dysfunction to in-
reased pulmonary pressures in patients with SCD. Invasive
emodynamic measurements have shown a mixed picture of
igh pulmonary artery pressures and elevated pulmonary
apillary wedge pressures (5,6), suggesting that LV diastolic
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January 30, 2007:472–9 Diastolic Dysfunction in Sickle Cell Diseaser systolic dysfunction may contribute to the high pulmo-
ary artery systolic pressures and increased risk of death.
herefore, our goal was to characterize LV structure and
unction in the SCD population and to relate echocardio-
raphic measures of dysfunction with PH and mortality.
ethods
atient population. This study was approved by the Na-
ional Heart, Lung, and Blood Institute Institutional Re-
iew Board, and all patients signed informed consent. The
tudy population consisted of 235 adult patients with
ocumented SCD (mean age 35  11 years, range 18 to 70
ears) and 41 age- and gender-balanced control patients
mean age 37  11 years, range 21 to 69) who were
onsecutively enrolled. Consistent with the distribution of
CD in the U.S., nearly all of the study patients were
frican American or African, with a very small percentage
f Hispanic patients. Consequently, healthy African Amer-
can patients were chosen as the most appropriate ethnically
omparable control group. This study included 191 patients
rom a subgroup of 195 patients who have been previously
escribed in detail (5). Nine patients with moderate or more
itral or aortic regurgitation were excluded from the study
opulation. The study population included 22 patients with
ild aortic regurgitation. At the time of their initial evalua-
ions, 37% of patients were on hydroxyurea therapy and no
atients were receiving treatment for PH.
chocardiography. Transthoracic echocardiography was
erformed with the use of the Acuson Sequoia (Siemens,
alvern, Pennsylvania) and Sonos 5500 (Philips, Andover,
assachusetts) systems. Echocardiograms were performed
t a community hospital and at a tertiary referral center
tarting in February 2001 and were read in a blinded
anner. Cardiac measurements were performed according
o American Society of Echocardiography guidelines (14).
he LV ejection fraction was assessed using the modified
uinones formula and the biplanar Simpson method (14).
easurement of stroke volume and cardiac output was
erformed in a standard manner (15). Left atrial volumes
ere measured using the biplanar method of discs incorpo-
ating both apical 4- and 2-chamber views (16). Tricus-
id regurgitation (TR) and pulmonary artery systolic
ressure were assessed as previously described (5). The
ean right atrial pressure was calculated according to the
egree of collapse of the inferior vena cava with inspira-
ion: 5 mm Hg for a collapse of at least 50% and
5 mm Hg for a collapse of 50% (17–19). Pulmonary
ypertension was prospectively defined as a peak TR jet
elocity of at least 2.5 m/s.
Left ventricular mass (LVM) and LV mass index
LVMI) were calculated using the formula described by
evereux et al. (20): LVM (g)  0.8 (1.04 [septum 
osterior wall  LV internal diastolic dimension]3 [LV
iastolic dimension]3)  0.6. Left ventricular hypertrophy
LVH) was defined as an LVMI higher than the 95th dercentile for children and adults
ith a gender-independent par-
ition value of 51 g/m2.7 (21).
elative wall thickness (RWT)
as defined as: (PW  2)/
VIDD (22). Patients with LVH
ad concentric hypertrophy if their
WT was elevated (0.41) and
ccentric LVH if their RWT was
ormal (0.41). Patients with a
ormal LVMI and increased
WT were classified as having
oncentric remodeling.
The LV and right ventricular
RV) areas were measured in the
pical 4-chamber view (23). The
V-to-LV area ratio at end-
iastole was calculated from
hese measurements. Right ventricular function was assessed
sing the RV percent change in area (14).
Diastolic function was assessed in all patients using
ulsed Doppler peak E and A velocities, E/A ratio, and
eceleration time (15,24). Isovolumic relaxation time was
easured as the time from aortic valve closure to the start of
itral inflow. After initial reports of elevated pulmonary
apillary wedge pressure in SCD patients undergoing car-
iac catheterization (5,6), we added tissue Doppler imaging
o the evaluation of patients undergoing echocardiogram
tarting in January 2003. The tissue Doppler imaging of the
eptal and lateral mitral annulus was performed in the subse-
uent 141 consecutive SCD echocardiograms. The peak Em
elocity was used to calculate a septal and lateral E/Em
atio. Diastolic dysfunction was graded as normal or as mild,
oderate, or severe dysfunction according to the criteria
escribed below. Because the SCD patients that we studied
ere young (average age 35  11 years) but had a wide
ange in age from 18 to 70 years, we defined a low E/A ratio
s 1.0 (representing approximately the 5th percentile of
ur population). Mild diastolic dysfunction was defined as
n E/A ratio of 1.0 and/or a deceleration time of 240
s. Moderate diastolic dysfunction was defined as an E/A
atio of 1.0 and an E/Em ratio of 10 (25). Severe
iastolic dysfunction was defined as an E/A ratio higher
han the 95th percentile for age (26) or deceleration time
DT) 140 ms (27) and E/Em 10.
tatistical analysis. Comparisons of distributions of con-
inuous variables in SCD patients and control patients, as
ell as in patients with TR jet velocity 2.5 and 2.5 m/s,
ere made using the t test. Associations between continu-
us variables were assessed using the Spearman rank corre-
ation coefficient. Adjustment for hemoglobin in bivariate
ssociations between TR jet velocity and echocardiographic
r laboratory variables was done by linear regression using
anks, with TR jet velocity the dependent variable and
emoglobin and the other variable of interest the indepen-
Abbreviations
and Acronyms
BP  blood pressure
LV  left ventricle/
ventricular
LVH  left ventricular
hypertrophy
PH  pulmonary
hypertension
RV  right ventricle/
ventricular
RWT  relative wall
thickness
SCD  sickle cell disease
TR  tricuspid regurgitant/
regurgitationent variable. Associations between a continuous and a
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Diastolic Dysfunction in Sickle Cell Disease January 30, 2007:472–9ichotomous variable were evaluated using the Wilcoxon
ank-sum test. Multiple linear regression modeling was used
o identify sets of variables that were independently associ-
ted with TR jet velocity. This modeling used a stepwise
rocedure in which a potential independent variable was
onsidered if it had a p value 0.15 for bivariate association
ith TR jet velocity; the final model included variables with
 0.05 in multiple regression. Multiple regression using
anks for all variables was used to confirm the most
mportant correlates. Associations of echocardiographic
ariables with mortality were assessed using proportional
azards (Cox) regression modeling. All p values0.05 were
onsidered statistically significant, and p values shown in the
ables were not adjusted for multiple comparisons; marked
alues represent associations that remain significant after a
onferroni correction, in which the p value is multiplied by
he number of comparisons in the table.
Because this was a registry study, prospective power
nalysis was not performed. Mortality data were collected by
eriodic telephone call or clinic follow-up and confirmatory
eview of the Social Security Death Index. Patients were
ollowed up until death or last contact with clinic staff, at
hich time they were censored.
esults
ardiac chamber morphology and systolic function. The
haracteristics of the 235 patients and 41 control patients
re shown in Table 1. Left and right heart chamber volumes
nd mass indexes were increased in the SCD patients
ompared with normal volunteers, as seen in Table 2. We
ound no significant difference in heart rate between SCD
atients and control patients, despite the fact that hemo-
lobin levels were significantly decreased in SCD patients.
here were 9 patients with concentric LVH, 7 patients with
ccentric LVH, and 35 patients with concentric remodeling.
n patients with a TR jet velocity of 2.5 m/s or more, LV
hamber size and mass increased (LV end-diastolic disten-
ion 52.9  5.9 vs. 50.4  4.6, p  0.001; LVMI 41.4 
2.9 vs. 33.5  8.3, p  0.001), although LV systolic
Characteristics of Sickle Cell Patients Versus N
Table 1 Characteristics of Sickle Cell Patie
SCD
n M
Age (yrs) 235 3
Female gender (%) 235
Heart rate (beats/min) 235 7
Systolic BP (mm Hg) 210 12
Diastolic BP (mm Hg) 211 6
Mean arterial pressure (mm Hg) 211 8
Creatinine (mg/dl)† 224 0.
Hemoglobin (g/dl) 226 9.
Ferritin (mg/l)† 219 88
Transferrin (mg/dl)† 224 20*For continuous variables, from 2-sided 2-sample t test; for gender, from chi
BP  blood pressure; SCD  sickle cell disease.unction did not change (p  0.2). The average LVEF was
5  8% (range 42% to 83%), and only 9% of patients had
vidence of systolic dysfunction with an ejection fraction
55%. Although there was a trend toward RV enlargement
ith increasing pulmonary pressures, RV systolic function
as preserved at higher pressures (RV percent area change
3  11 vs. 54  11, p  0.5), suggesting no evidence of
esting RV functional impairment. These echocardio-
raphic parameters were not significantly different in pa-
ients on hydroxyurea treatment.
revalence of diastolic dysfunction in patients with SCD.
ecause the most comprehensive diastolic assessment using
issue Doppler was available in 141 patients, we evaluated
he prevalence of diastolic dysfunction in this group and found
hat 25 patients (18%) had evidence of mild, moderate, or
evere diastolic dysfunction. Figure 1A shows the distribution
f patients with PH and diastolic dysfunction. There were 15
atients with mild diastolic dysfunction and 9 patients with
oderate diastolic dysfunction. We found that in patients with
ild diastolic dysfunction (E/A 1), Em was significantly
educed (9.4  3.4 vs. 11.3  3.4, p  0.04). Interestingly,
atients with moderate diastolic dysfunction had an E/A ratio
f only 1.2 0.2. In this group of 141 patients, there was only
patient with criteria for severe diastolic dysfunction.
We also examined the prevalence of PH in this group of
41 patients. We found 56 patients (40%) with a TR jet
elocity of 2.5 m/s and 15 patients (11%) with a TR jet
elocity of 3 m/s. As seen in Figure 1B, patients with
iastolic dysfunction were found at all levels of TR jet
elocity. Patients with moderate and severe diastolic dys-
unction, which may contribute to high filling pressures and
ubsequent high pulmonary pressures, were uncommon and
epresented only 9% of those with a TR jet velocity 2.5
/s (5 of 56 patients) and 13% of those with a TR jet
elocity 3 m/s (2 of 15 patients).
ssociations between PH and diastolic dysfunction. Be-
ause the elevation of pulmonary pressures in SCD patients
s mild, the contribution of LV systolic or diastolic dysfunc-
ion to PH remains controversial. We explored correlations
l Controls
ersus Normal Controls
Controls
p Value*SD n Mean  SD
41 37 11 0.50
41 59 0.93
41 70 12 0.10
36 133 19 0.001
36 77 12 0.001
36 95 14 0.001
3 41 0.9 0.2 0.909
8 41 13.5 1.6 0.001
325 38 75 61 0.001
37 271 51 0.001orma
nts V
ean 
5 11
60
3 11
1 18
7 11
5 12
9 1.
6 1.
0 1,
5 53-square without continuity correction; †logarithms (base 10) used.
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January 30, 2007:472–9 Diastolic Dysfunction in Sickle Cell Diseaseetween all echocardiographic and Doppler parameters and
R jet velocity. Table 3 shows that after adjustment for the
ffect of hemoglobin level and multiple comparisons, the
elationships with LV size, LVM, and left atrial area remain
ignificant, but only could explain approximately 10% to 15%
f the variability in TR jet velocities (2  0.06 for LVMI,
Echocardiographic and Doppler Features of SickControls
Table 2 Echocardiographic and Doppler FeaControls
SCD
n M
LV structure and function
LVED (mm) 233 5
LVES (mm) 233 3
Septal thickness (mm) 235
PW thickness (mm) 235
LVMI (g/m2.7) 214 3
LVEF (%)† 233 6
LV diastolic function
Max LA volume/BSA (ml/m2) 235 4
Peak E velocity (m/s) 225
Peak A velocity (m/s) 225
E/A ratio 225
Deceleration time (ms) 223 1
Isovolumic relaxation time (ms) 215
Right heart size and function
Right atrial area (cm2) 205 1
RV end-diastolic area (cm2) 182 1
RV end-systolic area (cm2) 182
RV area change (%) 179 5
RV:LV diastolic area ratio 182
*From t test; marked values represent associations with p  0.05 a
ejection fraction.
BSA  body surface area; LA  left atrium; LV  left ventricle; LV
fraction; LVES  left ventricle end-systolic dimension; LVMI  left
abbreviations as in Table 1.
Figure 1 Prevalence of Diastolic Dysfunction in Sickle Cell Dise
(A) Distribution of patients with pulmonary arterial hypertension (PH) and diastolic
regurgitation [TR] 2.5 m/s), with PH (TR 2.5) and tissue Doppler results indica
without or with mild, moderate, or severe DD are shown in groups based on their
velocity groups, there were no patients with severe DD..12 for left atrial area, 0.02 for E/A, and 0.03 for deceleration
ime). The LV systolic function did not correlate significantly
ith TR. In multiple regression modeling, right atrial area, LV
all thickness, lactate dehydrogenase (LDH), and transferrin,
reflection of iron overload, were the most important corre-
ates of TR velocity, all with p 0.05. A model using ranks for
ll Patients Versus Normal
of Sickle Cell Patients Versus Normal
Controls
p Value*SD n Mean  SD
5.1 41 47.6 3.8 0.001*
5.5 41 27.4 4.3 0.001*
1.5 41 8.9 1.1 0.043
1.4 41 9.0 1.1 0.038
10.8 31 30.4 6.2 0.002*
7.9 41 72.2 7.1 0.001*
13.8 41 22.8 5.9 0.001*
0.2 37 0.8 0.1 0.007
0.2 37 0.5 0.1 0.007
0.6 37 1.6 0.4 0.788
38 37 184 31 0.427
21 33 79 14 0.102
4.5 34 14.6 3.3 0.001*
4.7 34 17.4 4.3 0.017
3.0 34 8.0 1.8 0.056
11.0 32 53.9 9.8 0.998
0.1 34 0.5 0.1 0.430
nferroni adjustment for number of associations in table. †Quinones
ft ventricle end-diastolic dimension; LVEF  left ventricular ejection
ular mass index; PW  posterior wall; RV  right ventricle; other
ction (DD). Venn diagram indicating the number of patients without PH (tricuspid
D. (B) Detailed distribution by degree of PH and DD. The number of patients
velocity (TR 2.5 m/s, TR 2.5 to 2.9 m/s, and TR 3 m/s). In the 2 high TRle Ce
tures
ean 
1.3
2.7
9.4
9.4
6.2
5.2
0.5
0.9
0.6
1.6
89
73
7.9
9.5
9.0
3.9
0.5
fter Bo
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Diastolic Dysfunction in Sickle Cell Disease January 30, 2007:472–9ll of these variables gave similar results, except that the
ignificance of LDH was slightly decreased (p  0.08). The
ignificant, but weak, associations between measures of
iastolic dysfunction and TR velocity confirm the results of the
issue Doppler analysis: only a small subgroup of patients with
H has concomitant diastolic dysfunction that potentially
ontributes to elevated pulmonary pressures.
V diastolic dysfunction and PH are independent and
dditive risk factors for death. Of 235 patients, 3 had no
ollow-up for mortality, so the survival analysis included 232
atients. There were 20 deaths, and these patients were
ollowed up for 0.1 to 44.6 months (median 18.5 months).
he 212 survivors were followed up for 1.3 to 48.6 months
median 30.8 months).
ssociations With TR Velocity, Spearman Rank Correlation Coeffic
Table 3 Associations With TR Velocity, Spearman Rank Correla
Category Variable 
LV structure LVED (mm) 0.19
LVES (mm) 0.13
Septal thickness (mm) 0.29
PW thickness (mm) 0.27
LVMI (g/m2.7) 0.25
LV diastolic function Left atrial area (cm2) 0.35
MV E/A ratio 0.15
Deceleration time (ms) 0.18
IVRT (ms) 0.09
Septal Em/Am (cm/s) 0.05
Septal E/Em ratio 0.08
Right heart size and function Right atrial area (cm2) 0.33
RV end-diastolic area (cm2) 0.10
RV end-systolic area (cm2) 0.08
RV area change (%) 0.02
RV:LV diastolic area ratio 0.05
Laboratory Hemoglobin (g/dl) 0.28
LDH (U/l) 0.23
Creatinine (mg/dl) 0.18
Transferrin (mg/dl) 0.27
arked values represent associations with p  0.05 after Bonferroni adjustment for number of a
IVRT  isovolumic relaxation time; MV  mitral valve; TR  tricuspid regurgitation; other abbre
roportional Hazards (Cox) Regression Analysis of Mortality
Table 4 Proportional Hazards (Cox) Regression Analysis of Mor
Risk Factor Tot
MV E/A ratio (negative§) 2
TR jet velocity 2.5 m/s 2
MV peak E (negative§) 2
Deceleration time 2
Septal Em/Am (negative§) 1
Ejection fraction (negative§) 2
Septal peak Am 1
MV E/A ratio (negative§), adjusted for TR jet velocity (2.5 or 2.5 m/s) 2
TR jet velocity 2.5 m/s, adjusted for MV E/A ratio 2
MV E/A ratio (negative§) and TR jet velocity 2.5 m/s simultaneously 2
Totals differ because of missing values for some variables. Not included are three subjects with no
R jet velocity, RR is given for values values 2.5 (coded 1) relative to values 2.5 (coded 0). Fo
ercentile 25th percentile). For negative associations, 25th and 75th percentiles are reversed. §“Negati
CI  confidence interval; other abbreviations as in Table 3.Proportional hazards regression analysis showed that several
iastolic parameters, including E/A (p  0.001), peak E
elocity (p 0.002), deceleration time (p 0.002), and tissue
oppler septal Em/Am ratio (p  0.026), were independent
redictors of mortality. Patients with a low mitral E/A and a
ow tissue Doppler Em/Am ratio had a significantly increased
isk of mortality, with an RR (25th relative to 75th percentile)
f 4.8 (95% CI 1.9 to 12.1 for E/A, p 0.001 and 1.0 to 22.9
or Em/Am) (Table 4). The TR velocity remained a significant
redictor of mortality, with an RR of 5.1. After adjustment for
/A ratio, the RR for TR jet velocity 2.5 m/s was 3.4 (95%
I 1.2 to 9.4, p  0.014). In separate analyses of other
chocardiographic and Doppler variables, low EF (p  0.04)
as also found to be a significant independent risk factor for
Coefficient 
n p
Adjusted for Hemoglobin
 n p*
233 0.005 0.15 227 0.023
233 0.047 0.10 227 0.12
235 0.0001* 0.28 228 0.0001*
235 0.0001* 0.25 228 0.0002*
213 0.0002* 0.22 207 0.002*
235 0.0001* 0.29 228 0.0001*
225 0.022 0.22 218 0.001*
223 0.008 0.19 216 0.006
215 0.21 0.15 209 0.031
140 0.57 0.13 140 0.13
140 0.37 0.06 140 0.46
229 0.0001* 0.30 222 0.0001*
206 0.16 0.06 200 0.43
206 0.27 0.02 200 0.79
203 0.78 0.03 197 0.72
206 0.48 0.04 200 0.54
228 0.0001* n/a n/a n/a
205 0.0009* 0.07 204 0.32
227 0.005 0.24 226 0.0003*
224 0.0001* 0.20 223 0.002*
ions in table. *From regression on ranks.
s as in Table 2.
No. of Deaths p† Risk Ratio (RR)‡ 95% CI for RR
18 0.001 4.8 (1.9–12.1)
20 0.001 5.1 (2.0–13.3)
18 0.002 3.1 (1.5–6.8)
18 0.002 2.4 (1.4–4.1)
7 0.026 4.8 (1.0–22.9)
20 0.036 2.0 (1.0–3.8)
7 0.049 2.8 (1.1–7.5)
18 0.001 3.5 (1.5–8.4)
18 0.014 3.4 (1.2–9.4)
18 0.001 12.0 (3.8–38.1)
lity follow-up. †Likelihood ratio test. For pairs of variables shown, p 0.05 for both variables. ‡For
her variables, RR is given for 75th relative to 25th percentile, calculated as ecoefficient  (75thient 
tiontality
al*
22
32
22
20
41
30
41
22
22
22
morta
r all otve” indicates a continuous variable for which lower values are associated with higher risk of death.
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January 30, 2007:472–9 Diastolic Dysfunction in Sickle Cell Diseaseeath. The associations of echocardiographic parameters with
ortality were not explained by hemoglobin, LDH, creatinine,
irect bilirubin, or transferrin. The E/A ratio remained signif-
cantly associated with mortality ( 0.001) when adjusted for
ge, log10 creatinine, or mean arterial pressure, either separately
r simultaneously. For every 0.1-U decrease in the E/A ratio,
he mortality risk increased by 25% (95% CI 10% to 43%).
Importantly, when a high TR jet velocity and a low E/A
atio were present simultaneously, mortality increased signifi-
antly to an observed RR of 12.0 (95% CI 3.8 to 38.1).
onsistent with the proportional hazard regression analysis,
aplan-Meier survival curves show a significantly increased
ortality risk in patients having one or both of these risk
actors, compared with patients classified as lower risk based on
TR jet velocity of2.5 m/s or an E/A ratio of1.0 (Fig. 2).
linical correlates of diastolic parameters. There was a
ignificant correlation between the E/A ratio and blood
ressure (BP) (Spearman   0.29, p  0.0001 for
ystolic BP and   0.33, p  0.001 for diastolic BP).
atients with an E/A ratio of 1 had significantly higher
ystolic and diastolic BP values compared with patients with
n E/A ratio 1 (systolic BP 137  22 mm Hg vs. 119 
6 mm Hg, p  0.0001; diastolic BP 74  12 mm Hg vs.
7  11 mm Hg, p  0.007). These patients were older,
ad increased wall thickness and mass, and by tissue
oppler had lower septal and lateral Em velocities and
ower Em/Am ratios. There was a good correlation between
he E/A ratio and creatinine level (0.46, p 0.0001).
lthough markers of hemolysis correlated significantly with
hamber sizes and LVM (LDH vs. LVM/body surface area:
 0.34, p  0.0001), the association with diastolic
arameters was weak (LDH vs. E/A:   0.15, p  0.04,
DH vs. DT:   0.14, p  NS), suggesting that cardiac
Figure 2 Kaplan-Meier Survival Curve According
to Both TR Jet Velocity and E/A Ratio
Patients were classified as low risk if they had a tricuspid regurgitation (TR) jet
velocity of 2.5 m/s and an E/A ratio of 1.0. The high-risk group of patients had
either a TR velocity of 2.5 m/s or an E/A ratio of 1.0 or both. Mortality was
significantly increased in the group having one or both risk factors (p  0.0001).fdaptations to anemia have more of an effect on diastolic
unction than direct effects of hemolysis.
Although prospective studies will be necessary to define
ptimal BP levels in SCD patients, our study found the
5th and 90th percentiles for systolic BP to be 131 mm Hg
nd 144 mm Hg, respectively. Using either of these levels as
ut points, the SCD patients with lower BP values had
ignificantly decreased wall thickness and LVM and higher
/A values, suggesting that diastolic dysfunction had not
et developed. In patients with suspected LV diastolic
ysfunction (E/A 1), the pulse pressure was significantly
igher than in patients with an E/A 1 (63  19 vs. 52 
3, p  0.001).
iscussion
o our knowledge, this study represents the largest echocardio-
raphic study of cardiac function ever undertaken in patients with
CD. Our data suggest that 18% of all adults with SCD have
iastolic dysfunction and 11% have both PH and LV diastolic
ysfunction. We found some associations between measures of
iastolic dysfunction and TR jet velocities; however, the maxi-
um 2 value of 0.12 suggests that 20% of the observed
ariability in pulmonary artery systolic pressure is secondary to
iastolic dysfunction. Importantly, mild increases in pulmonary
ressures and diastolic LV filling abnormalities, when present
imultaneously, can predict high rates of mortality. Adjustment of
R velocity for E/A ratio in the Cox proportional hazards analysis
educes the RR from 5.1 to 3.5, and adjustment of E/A for TR
educes the RR from 4.8 to 3.4. Thus, these data strongly support
he thesis that PH, measured by echocardiographic Doppler, and
iastolic dysfunction develop largely independently, but can have
n important additive impact on mortality.
ardiac alterations in SCD. The hemodynamic conse-
uences of SCD are reflective of a volume overload state and have
een well described in earlier studies (12,28–32). Persistent
nemia results in a need for increased cardiac output, which is
chieved by dilation of all cardiac chambers with very little change
n heart rate. Dilation of the LV results in increased systolic wall
tress and compensatory LVH. Our study confirms findings from
n earlier series of 191 SCD patients (30) and shows no significant
mpairment of LV or RV systolic function in the majority of
atients. However, those with LV systolic dysfunction do
ave an increased risk for mortality. Although RV disease
as been proposed as one etiology for high mortality rates
n other diseases, such as idiopathic pulmonary arterial
ypertension (33), resting steady-state RV parameters
ere included in our survival analysis of SCD patients
nd were not found to be useful in the risk assessment of
hese patients.
revalence and prognosis of diastolic dysfunction in
CD. We found that diastolic dysfunction is common in
CD, and our findings agree with earlier reports of Doppler
lling abnormalities in SCD (28,31). Although a high E/A
atio has been associated with a worse outcome in heart
ailure (34) and acute myocardial infarction (35), the im-
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ecently (36). Our study extends these findings to the SCD
opulation and confirms prior associations among age,
lood pressure, and abnormal diastolic filling (37). In our
tudy, SCD patients with an E/A ratio of 1.0 were older
han the remaining patients and had significantly higher
ystolic and diastolic blood pressures and creatinine levels.
ecause E/A ratios are known to decrease with age (38), we
djusted for age as well as for mean arterial pressure and
ound that the association of a low E/A with mortality
emains significant. Tissue Doppler indexes support the
nding of mild or moderate relaxation abnormalities in the
atients at highest risk based on the E/A ratio, and suggest
hat the majority of these patients are distinct from the
roup with elevated pulmonary pressures.
echanisms of diastolic dysfunction. Diastolic dysfunc-
ion in SCD patients may be a consequence of relative
ystemic hypertension or direct myocardial damage from
ither microvascular vaso-occlusive disease or iron overload.
egelow et al. (39) have shown that the normal range of
lood pressure is lower in healthy SCD patients compared
ith the general population. They and others (39–41)
ound that those SCD patients with blood pressure values
bove the expected range for SCD patients, “relative sys-
emic hypertension,” had an increased risk of stroke and
eath. Our study findings suggest that patients with a low
/A ratio have higher blood pressures than the general
CD population, and the E/A ratio may be a marker for
nd-organ effects of relative systemic hypertension. This
s supported by the finding of increased wall thickness
nd mass in patients with low E/A ratios. Blood pressure
alues that would be considered normal for the general
opulation may be significantly elevated above the nor-
al range for SCD patients and may contribute to
ncreased risk in these patients through end-organ effects
n the heart and kidneys.
linical implications. There is a growing body of results
ssociating relative systemic hypertension with stroke, diastolic
ysfunction, and increased mortality in SCD patients, suggest-
ng the need for clinical trials to determine whether controlling
lood pressure to lower SCD norms would reduce morbidity
nd mortality. Not surprisingly, our study found an increased
revalence of diastolic dysfunction alone in older SCD patients
nd PH alone in younger patients. Redfield et al. (42) have
hown in a community population that even mild diastolic
ysfunction carries more than a 5-fold increase in mortality risk
ompared with patients with normal diastolic function. Our
esults, therefore, support the use of echocardiographic screen-
ng with supplemental cardiac catheterization confirmation in
dult SCD patients to identify high-risk individuals that may
enefit from additional treatment. Further studies are war-
anted to determine underlying etiologies for both the diastolic
ysfunction and PH.
tudy limitations. The results of this study are based on
ortality events in a relatively small group of patients withCD. The ability to obtain mechanistic insights into the
Eeaths is, therefore, limited. Although an E/A ratio of 1
dentifies a high-risk group in our study, this parameter is
nown to be dependent on intravascular volume status and
esults in SCD patients may be confounded by chronic anemia
nd fluid overload. Although we did not perform Valsalva
aneuvers or assess pulmonary venous profiles, our results are
upported by the tissue Doppler finding of septal Em/Am
aving an RR of 4.8 for mortality. It is possible that as
ollow-up time increases, we may find more prognostic infor-
ation from other tissue Doppler parameters. Because infor-
ation regarding cause of death is not yet available in this
egistry, it cannot be determined whether diastolic dysfunction
s a direct contributor to early death, or only a marker of overall
ealth status in SCD. Finally, because echocardiography has
nown limitations in the assessment of pulmonary pressures
nd LV filling pressures, it is imperative that suspected PH and
iastolic dysfunction by echocardiography be further evaluated
y invasive hemodynamic measurements.
onclusions. We found that diastolic dysfunction is com-
on in the SCD population, but only contributes directly to
he elevated pulmonary pressures in a small fraction of
atients with a high TR jet velocity. Of all echocardio-
raphic and Doppler parameters, the most important infor-
ation on risk assessment was obtained from the standard
/A ratio in combination with the TR jet velocity. The
resence of either a TR jet velocity2.5 m/s and/or an E/A
atio 1.0 identifies a high-risk group with a 4-year
ortality of approximately 60%. Early identification of the
iastolic dysfunction with echocardiography may allow early
ntervention of the underlying etiology. Diastolic dysfunc-
ion and PH can develop independently, each contributing
o increased mortality alone, and patients with both risk
actors have a poor prognosis. The apparent contribution of
elative hypertension to the development of diastolic dys-
unction in SCD suggests a compelling need for trials to
etermine whether correcting relative hypertension in pa-
ients with SCD will attenuate the development of diastolic
ysfunction and its associated mortality rate.
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